Send feedback

CDKL5 p.Pro527Ser

c.1579C>T · rs1275389347 · VCV590134

Likely benign Expert panel
Classification
Likely benign
ClinVar
Review
Expert panel ★★★☆
ClinVar · 3 submitters
AlphaMissense
likely benign
0.1141 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00351%, afr)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
2
CDKL5 disorder

ClinGen expert panel — Rett and Angelman-like Disorders VCEP

Likely Benign for CDKL5 disorder. Applied ACMG criteria (verbatim):

BS1 BS2_Supporting

Curation rationale (ClinGen, verbatim)

The allele frequency of the p.Pro527Ser variant in CDKL5 is 0.017% in African sub population in gnomAD, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The p.Pro527Ser variant is observed in at least 1 unaffected individual (internal database - Invitae) (BS2_supporting). In summary, the p.Pro527Ser variant in CDKL5 is classified as a Likely Benign based on the ACMG/AMP criteria (BS1, BS2_supporting).

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.1141likely benign
REVEL0.321indeterminate
SaProtLLR -6.18tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.7GERP 2.5, phastCons 1
Regional constrainto/e 0.70unconstrained · MANE · 30 kb · p 1.5e-11 · regional, not allelic
Overall
CADD24.5PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00351% African / African-American · 2/57,050 alleles
Filtering AF 0.00081% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000624%
Overall 0.00124% 15/1,209,798 alleles · very rare
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.00351% 28,525
European (non-Finnish) 0.00145% 68,859

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CDKL5
Protein
p.Pro527Ser
Coding
c.1579C>T
MANE Select
NM_001323289
dbSNP
rs1275389347
Type
single nucleotide variant
Location
chrX:18604503 (GRCh38)
Structure
AlphaFold pLDDT 53.76 · 3 PDB
Residue 527
the 'disordered' region
Full CDKL5 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdkl5-p-pro527ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown